Format

Send to

Choose Destination
Ann Hematol. 2006 Sep;85(9):631-2. Epub 2006 Jun 29.

Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab.

PMID:
16807748
DOI:
10.1007/s00277-006-0147-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center